EUVIMEDEUVIMED entdecken
Crossref

Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea

Ji Eun Na iD, Sung Hoon Jung iD, Arum Choi, Sukil Kim, Tae-Oh Kim iD

Mycoses · 2024

DOI: 10.1111/myc.13689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2024. Verfasst von Ji Eun Na und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, Korea. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), Ministry of Health & Welfare, Republic of Korea, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited reports exist regarding invasive fungal diseases (IFDs) in inflammatory bowel disease (IBD) patients.

Objectives

This study aims to investigate the incidence and risk factors of IFDs, specifically invasive candidiasis, aspergillosis and pneumocystosis, in IBD patients in South Korea using nationwide data. Patients/Methods A population‐based retrospective cohort of 42,913 IBD patients between January 2010 and December 2018 was evaluated using the Health Insurance Review and Assessment database. The primary outcome was the incidence of IFDs, including invasive candidiasis, aspergillosis and pneumocystosis, while the secondary outcome involved analysing the risk factors associated with each specific infection.

Results

The study included a total of 42,913 IBD patients, with 29,909 (69.7%) diagnosed with ulcerative colitis (UC) and 13,004 (30.3%) diagnosed with Crohn's disease (CD). IFDs occurred in 166 IBD patients (0.4%), with 93 cases in UC patients and 73 cases in CD patients. The incidence rates of invasive candidiasis, aspergillosis and pneumocystosis in IBD patients were 0.71 per 1000 person‐years (PYs), 0.15 per 1000 PYs and 0.12 per 1000 PYs, respectively. The cumulative incidence of invasive candidiasis (adjusted p ‐value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, PneumocystisInflammatory Bowel DiseasesColitis, UlcerativeCrohn DiseaseInvasive Fungal InfectionsCandidiasis, InvasiveAspergillosisHumansIncidenceRetrospective StudiesRepublic of Korea

Stichwörter der Autor:innen

inflammatory bowel diseaseinvasive fungal diseases

Autor:innen und Institutionen

  • Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, Korea.
  • Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Preventive Medicine and Public Health, College of Medicine, The Catholic University of Korea, Seoul, Korea.

ORCID-Profile: Ji Eun Na, Sung Hoon Jung, Tae-Oh Kim

Förderung

  • Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
  • Ministry of Health & Welfare, Republic of Korea
  • Korea Health Industry Development Institute

Zitieren

APA

Na, J. E., Jung, S. H., Choi, A., Kim, S., & Kim, T. O. (2024). Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea. Mycoses. https://doi.org/10.1111/myc.13689

Vancouver

Na JE, Jung SH, Choi A, Kim S, Kim TO. Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea. Mycoses. 2024. doi:10.1111/myc.13689

BibTeX
@article{Na2024,
  author = {Na, Ji Eun and Jung, Sung Hoon and Choi, Arum and Kim, Sukil and Kim, Tae-Oh},
  title = {Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea},
  journal = {Mycoses},
  year = {2024},
  doi = {10.1111/myc.13689}
}
Kostenlos starten →